Syneos Health Announces Acquisition of StudyKIK

Syneos Health has announced its acquisition of clinical trial solution company StudyKIK. The acquisition will bolster clinical trial recruitment efforts, including improving diversity in study design.

CEO of Syneos Health remarks, “StudyKIK’s patient-first focus, combined with their innovative enterprise platform, helps to advance our goal of bringing best-of-breed insights and technology-enabled solutions to biopharma customers, sites and patients,” adding, “We are excited to welcome the StudyKIK team to the Syneos Health family. Together we’ll accelerate product development by improving stakeholder experiences, realizing efficiencies in patient recruitment, engagement, improved access and diversity.” Read more here.

(Source: Syneos Health, 9/14/21)